Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients: Retrospective analysis of the national emphysema treatment trial

Chest

Volumn 134, Issue 3, 2008, Pages 497-506

  Drummond, Michael B ^a   Blackford, Amanda L ^b   Benditt, Joshua O ^c   Make, Barry J ^d   Sciurba, Frank C ^e   McCormack, Meredith C ^a   Martinez, Fernando J ^f   Fessler, Henry E ^a   Fishman, Alfred P ^g   Wise, Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chronic obstructive; Guideline adherence; Pulmonary disease; Supplemental oxygen

Indexed keywords

AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RISK PATIENT; HUMAN; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OXYGEN TENSION; OXYGEN THERAPY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; SURVIVAL TIME;

EID: 51649123732     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.08-0117     Document Type: Article

References (23)

1. Hoyert DL, Heron MP, Murphy SL, et al. Deaths: final data for 2003. Natl Vital Stat Rep 2006; 54:1-120
2. National Heart, Lung, and Blood Institute. Chronic Obstructive Lung Disease Fact Sheet. Bethesda, MD: US Government Printing Office, 2003; NIH publication No. 03-5229
3. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ ERS position paper. Eur Respir J 2004; 23:932-946
4. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management and prevention of COPD, 2006 update. Am J Respir Crit Care Med 2007; 176:532-555
5. National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease: national clinical guidelines on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004; 59:1-232
6. Wedzicha JA, Calverley PM, Seemungal TA, et al. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008; 177:19-26
7. Anthonisen NR, Skeans MA, Wise RA, et al. Lung Health Study Research Group: the effects of a smoking cessation intervention on 14.5-year mortality; a randomized clinical trial. Ann Intern Med 2005; 142:233-239
8. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980; 93:391-398
9. Report of the Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1:681-686
10. Gorecka D, Gorzelak K, Sliwinski P, et al. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxemia. Thorax 1997; 52:674-679
11. Haidl P, Clement C, Wiese C, et al. Long-term oxygen therapy stops the natural decline of endurance in COPD patients with reversible hypercapnia. Respiration 2004; 71:342-347
12. Cranston JM, Crockett AJ, Moss JR, et al. Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2005; 4:CD001744
13. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348:2059-2073
14. National Emphysema Treatment Trial Research Group. Rationale and design of the National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery. Chest 1999; 116:1750-1761
15. Martinez FJ, Foster G, Curtis JL, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173:1326-1334
16. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123:659-664
17. Crapo RO, Morris AH, Clayton PD, et al. Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir 1982; 18:419-425
18. Crapo RO, Morris AH. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981; 132:185-189
19. Weitzenblum E, Hirth C, Ducolone A, et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981; 36:752-758
20. Christensen CC, Ryg MS, Edvardsen A, et al. Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients. Eur Respir J 2004; 24:580-586
21. Takigawa N, Tada A, Soda R, et al. Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients. Respir Med 2007; 101:561-567
22. Emtner M, Porszasz J, Burns M, et al. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med 2003; 168:1034-1042
23. Pepin JL, Barjhoux CE, Deschaux C, et al. Long-term oxygen therapy at home: compliance with medical prescription and effective use of therapy: ANTADIR Working Group on Oxygen Therapy; Association Nationale de Traitement a Domicile des Insuffisants Respiratories. Chest 1996; 109:1144-1150